November Is National Pancreatic Cancer Awareness Month
As the month of November brings pancreatic cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment...
View ArticleStudy Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in...
Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall...
View ArticleAbraxane Plus Gemzar Improves Survival in Metastatic Pancreatic Cancer
Abraxane® (nab-paclitaxel) plus Gemzar® (gemcitabine) improved overall and progression-free survival in patients with previously untreated metastatic pancreatic cancer, according to the results of a...
View ArticleDual Vaccines Prolong Survival in Metastatic Pancreatic Cancer
The sequential delivery of two vaccines—GVAX and CRS-207—prolonged survival in patients with metastatic pancreatic cancer by about two months, according to the results of a study presented at the 2014...
View ArticleUpdated Analysis of the MPACT Study in Advanced Pancreatic Cancer...
A follow up report on the results of the Metastatic Pancreatic Adenocarcinoma Clinical Trial (MPACT) study of Abraxane® (nab-paclitaxel) in combination with Gemzar® (gemcitabine) in previously...
View ArticleIn Advanced Pancreatic Cancer, Eloxatin® with Folinic Acid and Fluorouracil...
In a Phase III study, the addition of the chemotherapy drug Eloxatin® (oxaliplatin) to the chemotherapy regimen of folinic acid and fluorouracil (5-FU) improved outcomes in patients with advanced...
View ArticleSimtuzumab Fails to Improve Outcomes in Pancreatic Cancer
Pancreatic cancer is one of the deadliest forms of cancer. Each year, approximately 43,000 people are diagnosed with pancreatic cancer in the United States and close to 37,000 die from the disease. The...
View ArticleFDA Grants Orphan Drug Designation to Investigational Agent for Pancreatic...
Pancreatic cancer is one of the deadliest forms of cancer. Each year, approximately 43,000 people are diagnosed with pancreatic cancer in the United States and close to 37,000 die from the disease. The...
View ArticleMM-398 Receives Fast Track Designation for Advanced Pancreatic Cancer
The U. S. Food and Drug Administration (FDA) has granted MM- 398 plus 5-fluorouracil (5-FU) and leucovorin a Fast Track designation as a second-line treatment for patients with metastatic pancreatic...
View ArticlePancreatic Cancer Cells Find Unique Fuel Sources to Keep from Starving
Pancreatic cancer cells avert starvation in dense tumors by ordering nearby support cells to supply them with an alternative source […] The post Pancreatic Cancer Cells Find Unique Fuel Sources to Keep...
View Article
